View Author
patient myeloma serum university hospital chain light blood progression protein department therapy cancer factor response study assay marrow transplant hematology mobilization institute signi mayo clinic ratio urine center leukemia signi ficance cell transplantation serum flc assay group clinic transplantation disorder disease gammopathy autologou collection amyloidosi plasma light chains flc assay ficance cell mobilization survival prince alfred hospital electrophoresis immunoglobulin cell collection kyle ra al amyloidosis measurement risk factor france table plerixafor medicine serum flc guideline high-dose trial high-dose therapy dispenzieri light chain value therneau tm risk factors number model group guidelines novel 100 ml diagnosis criteria baseline level risk-strati fication model light chain ratio reduction
4 Most Recent Publications
|
Plasma cell leukemia: Consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
(Article)
Fernández De Larrea, C. Kyle, R. Kumar, S. Mahindra, A. Comenzo, R.L. Palumbo, A. Mazumber, A. Anderson, K.C. Richardson, P.G. Badros, A.Z. Caers, J. Cavo, M. Durie, B.G.M. Leleu, X. Dimopoulos, M.A. Chim, C.S. Schots, R. Noeul, A. Fantl, D. Mellqvist, U.H. Landgren, O. Chanan-Khan, A. Moreau, P. Ludwig, H. Fonseca, R. Merlini, G. Lahuerta, J.J. Bladé, J. Orlowski, R.Z. Shah, J.J. Usmani, S.M. Vesole, D. Hajek, R. San Miguel, J-F. Sezer, O. Sonneveld, P. |
2013-04-01
|
|
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
(Article)
Kyle, R. Durie, B.G.M. San Miguel, J-F. Avet-Loiseau, H. Hajek, R. Chen, W. Anderson, K.C. Ludwig, H. Sonneveld, P. Pavlovsky, S. Palumbo, A. Richardson, P.G. Rajkumar, S.V. Barlogie, B. Greipp, P. Vescio, R. Turesson, I. Westin, J. Boccadoro, M. Landgren, O. Bladé, J. Merlini, G. Kröger, N. Einsele, H. Vesole, D. Dimopoulos, M.A. |
2010-04-22
|
|
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)
(Article)
Giralt, S. Stadtmauer, E.A. Merlini, G. San Miguel, J. Ludwig, H. Hajek, R. Jagannath, S. Blade, J. Lonial, S. Dimopoulos, M.A. Einsele, H. Barlogie, B. Harousseau, J-L. Anderson, K.C. Gertz, M. Attal, M. Tosi, P. Sonneveld, P. Boccadoro, M. Morgan, G. Sezer, O. Mateos, M.V. Cavo, M. Palumbo, A. Joshua, D. Turesson, I. Chen, W. Shimizu, K. Powles, R. Richardson, P.G. Niesvizky, R. Rajkumar, S.V. Durie, B.G.M. Bensinger, W. Comenzo, R.L. Kumar, S. Munshi, N.C. Dispenzieri, A. Kyle, R. |
2009-06-26
|
|
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
(Article)
Dispenzieri, A. Kyle, R. Dimopoulos, M.A. Comenzo, R.L. Einsele, H. Barlogie, B. Anderson, K.C. Gertz, M. Harousseau, J-L. Attal, M. Tosi, P. Sonneveld, P. Merlini, G. Boccadoro, M. Morgan, G. Richardson, P.G. Sezer, O. Mateos, M.V. Cavo, M. Joshua, D. Turesson, I. Chen, W. Shimizu, K. Miguel, J.S. Powles, R. Rajkumar, S.V. Durie, B.G.M. Ludwig, H. Hajek, R. Palumbo, A. Jagannath, S. Bladé, J. Lonial, S. |
2009-01-01
|
